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Abstract 
Background: Vascular calcification is a common finding in abdominal aortic aneurysms 
(AAA) however whether it predicts aneurysm expansion is controversial.  
Objectives: 1) To establish a reproducible method of assessing AAA calcification using 
computed tomography (CT); 2) To investigate the association between AAA calcification and 
growth. 
Method: Patients were identified from a prospectively maintained small AAA surveillance 
database. To be included patients required at least two CT scans a minimum of 6 months 
apart. All patients had a maximal AAA diameter of ≤ 55mm on their initial scan. Infra-renal 
aortic calcification volume, total infra-renal aortic volume and maximal AAA diameter were 
measured. Reproducibility was assessed from repeat scans performed on 31 patients. AAA 
growth, estimated by volume change per year, was compared between patients with baseline 
infra-renal aortic calcification volumes < and ≥ median.  
Results: 95% agreement limits (lower, upper) for inter and intra-observer error in measuring 
infra-renal aortic calcification volume were 0.68, 97 mm3 and -140, 5.8 mm3, respectively. 
Concordance correlation coefficients for inter and intra-observer variability in measuring 
infra-renal aortic calcification volume were 0.99 and 0.99, respectively. Patients with infra-
renal aortic calcification volume  < median (n=44) and  ≥ median (n=44) had an infra-renal 
aortic volume increase of 6.0 cm3/yr and 7.8 cm3/yr, respectively (p=0.66).  Mean percentage 
infra-renal aortic volume increase/yr was found to be 4.2±6.4 and 8.9±6.2 for patients with 
and without diabetes, respectively (p=0.003).  
Conclusion: Infra-renal aortic calcification volume can be assessed reproducibly from CT 
images. Infra-renal aortic calcification volume did not predict small AAA growth.  
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  Introduction 
Abdominal aortic aneurysm (AAA) is an important cause of mortality in older adults. There 
are currently no established drug therapies to limit AAA growth and surgical intervention 
does not reduce mortality of patients with small AAAs (1-3). As a result, most patients with 
small AAAs undergo imaging surveillance until AAA diameter is ≥ 50-55 millimetres (mm). 
Despite such surveillance, 1-2% of small AAAs rupture per year (4, 5). Additional measures of 
selecting patients for intervention are needed (6).  
AAA rupture represents a mechanical failure of the degenerated aortic wall, thus 
biomechanical considerations are important to understand this process and to improve our 
predictions of its occurrence (7). Patient specific biomechanical profiling has been suggested 
as a potentially valuable tool in rupture risk assessment (8, 9). Additionally, peak wall stress 
(PWS) has been reported to be greater in ruptured and symptomatic AAAs compared to 
asymptomatic AAAs (10), and PWS has been reported to predict location of future rupture (9, 
11)
. Furthermore, finite element analysis (FEA) studies have demonstrated that PWS is 
significantly greater in AAA regions with calcified plaque compared to regions with no 
calcification (12). Abdominal aortic calcification (AAC) score has also been reported to be 
higher in symptomatic and ruptured AAAs compared to asymptomatic AAAs (13). A recent 
study evaluating AAA tissue specimen has implicated AAA calcification in determining 
rupture risk (14). However, a multi-detector computed tomography study suggested that 
calcified plaques are smaller in AAA compared to normal abdominal aortas (15). Thus the role 
of calcification in AAA pathogenesis has not been clearly elucidated.   
A previous study reported that greater AAA calcification was associated with slower AAA 
expansion. In that study calcification was assessed semi-quantitatively by ultrasound (US) 
and inter-observer reproducibility was not reported. Furthermore analyses did not adjust for 
baseline AAA size (16). A further small study which used computed tomography (CT) 
imaging to assess AAA calcification reported no association between AAA calcification 
volume and growth (17).  The nature of the relationship between infra-renal aortic calcification 
volume and small AAA growth is yet to be resolved. Studies investigating AAA calcification 
have employed variable methods of quantifying calcification and frequently not reported the 
assessment reproducibility (18).   
The aims of the current study were: 
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1. To establish a valid and reproducible method of assessing infra-renal aortic 
calcification with CT; 
 
2. To investigate the association between infra-renal aortic calcification volume and 
AAA growth rate. 
 
 
2. Methods 
2.1 Patients and clinical definitions 
We performed a retrospective analysis of serial CT images of patients with small AAAs that 
were under surveillance at The Townsville Hospital (TTH) between June 2003 and 
November 2013. Such patients had previously consented to their medical information being 
confidentially stored in a database and used for research purposes. A low, negligible risk 
ethics application for this study was approved by TTH Human Research and Ethics 
Committee (HREC) (approval number 13/QTHS/125) and endorsed by James Cook 
University HREC.  
To be included patients had to have undergone at least two CT scans a minimum of 6 months 
apart and images had to be available for retrospective analysis. All patients had a maximal 
axial AAA diameter of ≤ 55mm on their initial scan. Repaired and mycotic AAAs were 
excluded. Patients with connective tissue diseases, such as Marfan’s syndrome, were 
excluded.  
Ischemic heart disease (IHD) was defined by a history of myocardial infarction, angina 
pectoris or coronary revascularisation. Hypertension and diabetes mellitus (DM) were 
defined by previous history or treatment for these conditions. Cigarette smoking classification 
was based on smoking history and defined as current smoker (smoked within the last month), 
ex-smoker (smoked previously but not in the last month) or never smoked.  
 
2.2 CT acquisition 
All CTs were performed at TTH using a 64 slice multi scanner (Philips, North Ryde, NSW), 
under a set acquisition protocol (19). Abdominal aortic images were obtained in a single breath 
hold cycle in 3 mm slices at 3 mm intervals. 100 mL Ultravist 300 was delivered 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
intravenously using an automated injection driver system. Image capture commenced when 
the locater set above the renal arteries detected that Hounsfield units at the centre of the aorta 
reached 130.  
2.3 Assessment of infra-renal aortic calcification 
Original CT images were transferred onto a Philips MxView Visualisation Workstation 
software for detailed analysis. The region of interest (ROI) was the slice inferior to the origin 
of the lowest renal artery to the slice superior to the bifurcation of the abdominal aorta. 
Firstly, axial images throughout the ROI were scouted to carefully demarcate the outer 
boundary of the aortic wall. The outer aortic wall was traced free hand with the cursor under 
magnified images to improve accuracy and to exclude adjacent bowel tissue, vertebral body 
tissue and all non-aortic tissue from the ROI. Secondly, coronal images were also scouted to 
identify the upper and lower boundaries of the ROI as described above.  Calcification volume 
was subsequently extracted from the ROI using a workstation tool based on predefined and 
validated thresholds of radio density for calcification(19) as illustrated in  Figure 1. Results 
were transcribed onto an excel spreadsheet for further analysis.  
2.4 Assessment of infra-renal aortic volume and AAA diameters 
Infra-renal aortic volume was assessed using methods similar to those used to measure infra-
renal aortic calcification volume. After selecting the ROI and abdominal aortic boundary 
from axial slices, the total infra-renal aortic volume was estimated based on predefined and 
validated radio density set up on the Phillips workstation (19). AAA orthogonal diameter was 
measured by first scouting axial images within the ROI to identify the abdominal aortic 
centre point in each axial slice. Subsequently, images perpendicular to the AAA centreline 
were analysed to measure the maximal orthogonal diameter including the outer wall and 
thrombus. AAA growth was estimated from two CT scans, at least six months apart, for all 
patients. Growth was calculated by normalising the respective volume and diameter changes 
relative to the time interval between CTs for each patient and reporting as changes per year.   
2.5 Reproducibility 
In order to determine the repeatability of calcification measurements we assessed the 
agreement of measurements between and within observers on 31 patients. This involved two 
final year medical students, each trained by an experienced doctor, measuring and recording 
the calcification volume from CTs whilst being blinded to each other’s results. Measurements 
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were then repeated at least 24 hours later by one observer (KH) to assess the intra-observer 
error.  
2.6 Statistical analysis 
Statistical analysis for reproducibility was performed according the methods outlined by 
Bland and colleagues (20). Furthermore, concordance correlation coefficient were calculated 
according to Lin (21).  
To test our hypothesis that patients with infra-renal aortic calcification volume below median 
would experience a greater AAA volume increase compared to those with calcification 
volume equal to or above median, patients were divided into two groups. Group 1 has infra-
renal aortic calcification volume less than median and group 2 has an infra-renal aortic 
calcification volume greater than or equal to median.  
The required sample size was calculated based on two assumptions. Firstly, mean AAA 
volume growth/year in patients with calcification volume < median was assumed to be 
12cm3/yr, SD = 6.5 cm3/yr. based on results from a previous CT study (17). Secondly we 
predicted that AAA growth rate would be 42 % greater in patients with calcification volume 
< median as suggested by results from a study by Lindholt and colleagues (16). Using the G-
power 3.1.9.2 tool, (Two tailed t-test: difference between means α = 0.05, Power = 0.95), 30 
observations in each group were needed. 
All results were transcribed onto an excel spreadsheet and later transferred to SPSS version 
22 (IBM SPSS) for statistical analysis. Chi squared t-test and Mann-Whitney U test were 
used to compare nominal and continuous variables, respectively, between groups. Medians 
and interquartile ranges were reported for variables which were not normally distributed and 
means and standard deviations were used to describe results for continuous variables 
following a normal distribution.  Correlation analyses were performed between continuous 
variables where the dependant variable followed a normal distribution and reported as 
Pearson’s correlation coefficient.  
 
3. Results 
Records of 173 patients who underwent serial CT imaging of their AAA between June 2003 
and Nov 2013 were screened for inclusion into the study. A total of 88 patients met eligibility 
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criteria and were included. Median time interval between the two CT scans assessed from 
each patient was 16 months, interquartile range 12 to 28 months. Thirty percent of the cohort 
were current smokers at recruitment and 74% were male. The median baseline infra-renal 
aortic calcification volume for the cohort was 1600 mm3, interquartile range of 830 – 2800 
mm
3
. Median baseline infra-renal aortic volume was 91 cm3 with an interquartile range of 73 
– 108 cm3.  Mean baseline orthogonal diameter was 43.0 mm, standard deviation was 5.5 
mm.  
3.1 Reproducibility 
31 subjects were involved in the reproducibility study. Inter-observer and intra-observer 95% 
limits of agreement for infra-renal aortic calcification volume were (lower, upper):  -140, 5.8 
mm
3
 and 0.68, 97 mm3, respectively. Ninety-five percent limits of agreement for infra-renal 
aortic volume were (lower, upper); -4.5, 0.027 cm3 and -0.007, 3.0 cm3 for inter and intra-
observer error respectively. The concordance correlation coefficients (CCC) for inter-
observer and intra-observer variability in measuring infra-renal aortic volume were 0.98 and 
0.99, respectively. In measuring infra-renal aortic calcification volume the CCCs were 0.99 
and 0.99 for inter-observer and intra-observer variability, respectively (Table 1).  
3.2 Association of aortic calcification with AAA expansion 
None of baseline characteristics assessed were significantly different between the groups with 
<median or ≥median calcification volume (Table 2). Median infra-renal aortic volume 
increase in the group with <median calcification was 6.0 cm3/yr compared to 7.8 cm3/yr in 
the group with ≥median (p = 0.66). Median AAA orthogonal diameter increase was 1.6 
mm/yr in the group with <median calcification and 1.8 mm/yr for the group with ≥median (p 
= 0.99). Actual and percentage AAA growth rates were similar in both groups (table 3). Infra-
renal aortic calcification volume had minimal correlation with percentage AAA volume 
change/yr (Pearson correlation = 0.10, p= 0.36). Mean percentage AAA volume change/yr 
was 4.2±6.4% and 8.9±6.2% for patients with and without diabetes, respectively (p=0.003).  
 
 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
4. Discussion 
The findings from this study suggest that infra-renal aortic calcification volume can be 
measured from CT with good inter and intra-observer reproducibility compared to other 
published studies on the subject (17, 22). Results from this cohort suggest that infra-renal aortic 
calcification volume is not significantly associated with small AAA growth rates. Findings 
from this cohort of patients are consistent with previous US and CT based studies in reporting 
that diabetes mellitus is associated with reduced AAA growth rates (1, 23, 24).  
Patients with diabetes are believed to have more marked vascular calcification and thus one 
possible explanation for reduced AAA expansion in these patients could be through more 
advanced aortic calcification (25).  Our findings however suggest that aortic calcification does 
not explain the reduced AAA expansion in patients with diabetes. The changes seen in the 
walls of aneurysmal aortas include inflammation and the activation of proteolytic pathways 
associated with loss of elastin and other structural proteins (26). In contrast, diabetes is 
associated with increased synthesis and reduced degradation of extracellular matrix. The 
deposition of advanced glycosylation end products also renders vascular matrix resistant to 
proteolysis and inflammation in patients with diabetes (25). It is likely these changes in the 
extracellular matrix are responsible for the reduced AAA expansion in patients with diabetes 
rather than any effects of aortic calcification. 
 
Previous studies have alluded to the potential that AAA calcification may be a novel 
additional tool for AAA rupture risk assessment (13). This has been supported by FEA 
findings of increased PWS in AAA regions with calcified plaque (9-11). However our results 
did not suggest a significant association between infra-renal aortic calcification volume and 
AAA growth. This suggests that incorporating AAA calcification in rupture risk assessment 
is unlikely to improve accuracy of predicting rupture, although a larger long term prospective 
study would be needed to confirm this. Thus we currently have insufficient evidence to 
necessitate consideration of infra-renal aortic calcification volume when selecting patients for 
intervention. Additionally, this study contributes to the evidence refuting the theory that 
suggests heavily calcified AAAs grow slower than less calcified AAAs. This is important in 
avoiding misconceived alterations to AAA surveillance periods based on the degree of AAA 
calcification. Our current data suggests that calcified AAAs should have similar imaging 
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surveillance as other AAAs. Moreover, our findings do not support the exploration of 
pharmacological manipulation of AAA calcification as a means to slow expansion of AAAs.     
  
This study has a number of limitations. Firstly, only 88 patients were included in the current 
study. We based this on a sample size calculation which assumed a 42% difference in AAA 
growth rate between the two groups thus we were underpowered to examine smaller 
differences in AAA growth. We assessed AAA growth from CT scans performed at varying 
intervals. In order to adjust for these differences in time intervals we had to assume linear 
AAA growth which is not always the case although we found this to be present in a recent 
cohort (27). Furthermore, the possibility of selection bias should be noted. Patients who 
undergo CT rather than US surveillance are commonly those with one or more of the 
following attributes: Increased body habitus, a particularly tortuous aorta, and those with a 
large baseline AAA diameter. On the other hand, patients presumably omitted from this 
cohort include those who may need CT imaging but are at increased risk of contrast induced 
nephropathy. Finally we only assessed aortic calcification volume. It is conceivable that other 
aspects of calcification like is distribution or thickness might have separate impact on the 
growth of small AAAs however we suspect this is unlikely given the lack of association of 
calcification volume. 
In conclusion despite the established association of vascular calcification with increased 
incidence of cardiovascular events (28), infrarenal aortic calcification volume does not appear 
to be associated with small AAA growth. The finding of the current study is consistent with 
findings from a previous study by our group (17). 
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Table 1: Reproducibility assessment 
 
 
 95 % Limits of agreement 
(lower, upper) 
Concordance correlation 
coefficient (95 % CI) 
 Intra observer error 
Infra-renal aortic volume 
(cm
3
) 
-0.007, 3.0 0.99 (0.99 – 1.0) 
Infra-renal aortic  
calcification volume (mm
3
) 
0.68 , 97 0.99 (0.998 – 1.0) 
 Inter observer error 
Total  Infra-renal aortic  
volume (cm
3
) 
-4.5, 0.027 0.98 (0.97 - 0.99) 
Infra-renal aortic  
Calcification volume 
(mm
3
) 
-140, 5.8 0.99 (0.99 – 1.0) 
CI: confidence interval 
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Table 2: Clinical risk factors in patients with infra-renal aortic calcification volumes < 
median and  ≥ median 
  Total cohort  
(n = 88) 
<median  
(n= 44) 
≥median  
(n = 44) 
P-value 
Male Gender 65 (74%) 35 (80%) 30 (68%) 0.33 
Current Smoker 26 (30%) 9 (20%) 17 (38%) 0.10 
Diabetes Mellitus 24 (27%) 12  (27%) 12 (27%) 1.0 
Hypertension 65 (74%) 30 ( 68%) 35 (80%) 0.33 
Ischemic Heart 
Disease 
46 (52%) 25 (45 %) 21 (48%) 0.52 
Calcium Channel 
Blocker 
22 (25%) 10 (22%) 12 (27%) 0.81 
ARB 17 (19%) 12 (27%) 5 (11%) 0.10 
ACE inhibition 35 (40%) 17 (38 %)  18 (41%) 1.0 
 
 
 
ARB: Angiotensin II receptor blocker. ACE: Angiotensin converting enzyme.  
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Table 3: Comparison of AAA growth in patients with infra-renal aortic calcification volume 
< median and ≥ median 
 
 
 
 Total Cohort (n = 88) < median 
(n = 44) 
≥ median  
(n = 44) 
P-value 
Age (years) 72 (66, 77) 71 (65, 76) 73 (68, 78) 0.13 
Infra-renal aortic 
Thrombus Volume 
(cm
3
) 
27 (17,36) 23 (15 , 35) 28 (24, 39) 0.22 
Volume change 
(cm
3
/year) 
6.5 (1.7, 12) 6.0 (1.7, 12) 7.8 (1.7, 12) 0.66 
Orthogonal 
diameter change 
(mm/year) 
1.7 ( 0.66, 2.9) 1.6 (0.7, 
3.0) 
1.8 (0.5, 2.9) 0.99 
 Volume change/year 
(%) 
7.3 (3.0,12) 8.0 (2.8, 12) 7.2 (3.1, 11) 0.80 
 orthogonal diameter 
change/year (%) 
3.6 (1.7,6.6) 3.4 (1.9, 
7.5) 
4.1(1.1, 6.4) 0.89 
cm: centimetres. P-value is reported comparing group 1 and group 2.  
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Figure 1: Computed tomography images illustrating the method of assessing infra-renal aortic 
calcification volume 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
a. 
 
b. 
c. 
Fig 1. Three images displaying the acquisition of infra-renal aortic 
calcification volume.  The coronal view of the abdominal aorta with the 
green lines at the upper and lower boundaries set at the slice inferior to 
the lowest renal artery and the slice above the aortic bifurcation 
respectively (a).  The axial images depict the selection of aortic boundary 
to include outer wall (b). The extracted calcification volume from the 
region of interest is calculated based on predefined thresholds for a 
calcification specific radio-density spectrum. A 3D reconstruction of the 
calcium volume within the region of interest is depicted in (c).  
